Alport Research Hub Symposium 2026, London

Published on 03/07/2026

03 July 2026
London, UK

ENYO Pharma will attend the third annual symposium of the Alport Research Hub organized by Alport UK association.

ENYO Pharma will meet patients and their families and present the results of the Phase 2 “ALPESTRIA-1” clinical study with Vonafexor in Alport syndrome patients: “Vonafexor: Phase 2 Efficacy and Safety Results in Progressive Alport Syndrome

https://www.kidneyresearchuk.org/research/information-for-researchers/rare-and-paediatric-kidney-diseases/alport-research-hub/alport-symposium//

Read next in 'Events'

• ASN 2026 - American Society of Nephrology
• ASN - the American Society of Nephrology 2026
• PinUp Casino Kayıt Rehberi: Adım Adım Hesap Açma
• Boo Casino NZ Review: How It Works, Bonuses and Game Selection
• Boo Casino Handbook: A Practical Guide for New Zealand Players